n-methyl-3,4-methylenedioxyamphetamine has been researched along with Heart Diseases in 5 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Additional studies are needed to determine the effects of chronic administration of amphetamines on circulating 5-HT." | 1.33 | Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. ( Baumann, MH; Rothman, RB; Zolkowska, D, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonsignore, A | 1 |
| Barranco, R | 1 |
| Morando, A | 1 |
| Fraternali Orcioni, G | 1 |
| Ventura, F | 1 |
| Shenouda, SK | 1 |
| Carvalho, F | 1 |
| Varner, KJ | 2 |
| Badon, LA | 1 |
| Hicks, A | 1 |
| Lord, K | 1 |
| Ogden, BA | 1 |
| Meleg-Smith, S | 1 |
| Zolkowska, D | 1 |
| Rothman, RB | 1 |
| Baumann, MH | 1 |
| Dowling, GP | 1 |
| McDonough, ET | 1 |
| Bost, RO | 1 |
2 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Heart Diseases
| Article | Year |
|---|---|
MDMA Induced Cardio-toxicity and Pathological Myocardial Effects: A Systematic Review of Experimental Data and Autopsy Findings.
Topics: Adolescent; Amphetamine-Related Disorders; Animals; Autopsy; Cardiotoxicity; Cause of Death; Female; | 2019 |
The cardiovascular and cardiac actions of ecstasy and its metabolites.
Topics: Animals; Hallucinogens; Heart; Heart Diseases; Humans; Models, Cardiovascular; N-Methyl-3,4-methylen | 2010 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Heart Diseases
| Article | Year |
|---|---|
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Drug Interactions; Electrocardiography; Hallucinog | 2002 |
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relations | 2006 |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Accidents; Adolescent; Adult; Amphetamines; Arrhythmias, Cardiac; Ast | 1987 |